Knowledge on rare diseases and orphan drugs
COVID-19 & Rare diseases
Rare Diseases Resources for Refugees/Displaced Persons
Search for a rare disease
PMM2-CDG
A rare congenital disorder of N-glycosylation and is characterized by cerebellar dysfunction, abnormal fat distribution, inverted nipples, strabismus and hypotonia. 3 forms of PMM2-CDG can be distinguished: the infantile multisystem type, late-infantile and childhood ataxia-intellectual disability type (3-10 yrs old), and the adult stable disability type. Infants usually develop ataxia, psychomotor delay and extraneurological manifestations including failure to thrive, enteropathy, hepatic dysfunction, coagulation abnormalities and cardiac and renal involvement. The phenotype is however highly variable and ranges from infants who die in the first year of life to mildly involved adults.
ORPHA:79318
Classification level: Disorder
- CDG syndrome type Ia
- CDG-Ia
- CDG1A
- Carbohydrate deficient glycoprotein syndrome type Ia
- Congenital disorder of glycosylation type 1a
- Congenital disorder of glycosylation type Ia
- Phosphomannomutase 2 deficiency
Prevalence: Unknown
Inheritance: Autosomal recessive
Age of onset: Infancy, Neonatal
: produced/endorsed by ERN(s)
: produced/endorsed by FSMR(s)
General public
Guidelines
Disease review articles
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
- Research project(s) (58)
- Clinical trial(s) (3)
- Biobank(s) (11)
- Registry(ies) (26)
- Network of experts (8)
Newborn screening